share_log

Illumina | 4: Statement of changes in beneficial ownership of securities-Officer Wedel Christensen Jakob

Illumina | 4: Statement of changes in beneficial ownership of securities-Officer Wedel Christensen Jakob

Illumina | 4:持股变动声明-高管 Wedel Christensen Jakob
美股SEC公告 ·  2024/12/10 06:16

Moomoo AI 已提取核心信息

On December 6, 2024, Jakob Wedel Christensen, SVP of Strategy and Corporate Development at Illumina, sold 396 shares of common stock at $140.02 per share. The transaction was executed as part of a payment for exercise price or tax liability by delivering or withholding securities.The total value of the disposed shares amounted to $55,447.92. Following this transaction, Christensen's direct ownership in Illumina decreased to 6,759 shares. The sale was reported as a completed transaction, indicating that all regulatory requirements have been met.This insider transaction provides insight into executive stock movements at Illumina, a leading company in the genetic sequencing industry. Such sales by senior executives are often closely monitored by investors for potential signals about the company's future prospects or valuation.
On December 6, 2024, Jakob Wedel Christensen, SVP of Strategy and Corporate Development at Illumina, sold 396 shares of common stock at $140.02 per share. The transaction was executed as part of a payment for exercise price or tax liability by delivering or withholding securities.The total value of the disposed shares amounted to $55,447.92. Following this transaction, Christensen's direct ownership in Illumina decreased to 6,759 shares. The sale was reported as a completed transaction, indicating that all regulatory requirements have been met.This insider transaction provides insight into executive stock movements at Illumina, a leading company in the genetic sequencing industry. Such sales by senior executives are often closely monitored by investors for potential signals about the company's future prospects or valuation.
2024年12月6日,illumina的战略和企业发展高级副总裁雅各布·维德尔·克里斯滕森出售了396股普通股,售价为每股140.02美元。该交易作为支付行使价格或税务责任的一部分,通过交付或扣留证券来执行。所处置股份的总价值为55,447.92美元。此次交易后,克里斯滕森在illumina的直接持股减少至6,759股。该销售被报告为已完成交易,这表明所有监管要求已得到满足。这一内部交易为illumina高管的股票动态提供了洞察,illumina是一家领先的基因测序行业公司。这些高管的销售通常受到投资者的密切关注,因为它们可能暗示公司未来的前景或估值。
2024年12月6日,illumina的战略和企业发展高级副总裁雅各布·维德尔·克里斯滕森出售了396股普通股,售价为每股140.02美元。该交易作为支付行使价格或税务责任的一部分,通过交付或扣留证券来执行。所处置股份的总价值为55,447.92美元。此次交易后,克里斯滕森在illumina的直接持股减少至6,759股。该销售被报告为已完成交易,这表明所有监管要求已得到满足。这一内部交易为illumina高管的股票动态提供了洞察,illumina是一家领先的基因测序行业公司。这些高管的销售通常受到投资者的密切关注,因为它们可能暗示公司未来的前景或估值。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息